Wassermann K, Koch A, Müller-Ehmsen J, Reuter M, Michel O, Eckel H E
Third Department of Internal Medicine, University of Cologne, Germany.
J Thorac Cardiovasc Surg. 1997 Oct;114(4):527-34. doi: 10.1016/S0022-5223(97)70040-0.
Although widely established in the management of malignant airway lesions, currently available tracheobronchial prostheses made of silicone have their drawbacks resulting from rigidity and wall thickness. Therefore we present clinical follow-up data obtained with a novel thin-walled expandable prototype silicone airway stent (Polyflex stent, Willy Rüsch AG, Kernen, Germany) in 19 patients.
Seventeen of 19 patients had tracheobronchial complications of infiltrating cancer: five had respiratory-digestive fistulas, 14 had mixed-type obstructions (mucosal infiltration plus extrinsic compression), and two had diffuse tracheal hemorrhages from the tumor surface (three patients had more than one complication). Two of 19 patients had benign postintubation stricture and malacia. Overall, 33 stents were implanted either simultaneously or in a consecutive manner. Scanning electron microscopy was performed both on prototype stents and on other available silicone stents for comparison.
The treatment improved the patients' clinical condition substantially. The mechanical properties of the new prosthesis were excellent. Important stent-associated side effects were early mucus retention (n = 7), infolding of the inner silicone layer (n = 2), and stent dislodgment (n = 2). As of February 1997, 10 patients have died of causes unrelated to stent placement. Seven patients with malignant airway disease are still alive from 2 weeks up to 7 months after initial treatment. Scanning electron microscopy of explanted and unused prototypes suggested that an extremely ragged luminal microstructure may contribute to the firm adhesion of secretory material and that technical smoothing of the surface avoids such complications.
The novel self-expandable silicone airway stent may be a promising addition to commonly used stent types. Short-term and medium-term management of fistulas, tumor surface bleeding, and strictures (malignant and benign) is satisfactory. Scanning electron microscopy of stents provides information on peculiar features of microstructure and material that may be of use in clinical research and technical innovation.
尽管目前市售的硅酮气管支气管假体在恶性气道病变的管理中广泛应用,但因其硬度和壁厚而存在缺陷。因此,我们展示了19例患者使用新型薄壁可扩张硅酮气道支架原型(Polyflex支架,德国威利·鲁施公司,克嫩)的临床随访数据。
19例患者中,17例有浸润性癌的气管支气管并发症:5例有呼吸消化道瘘,14例有混合型梗阻(黏膜浸润加外压),2例有肿瘤表面弥漫性气管出血(3例患者有不止一种并发症)。19例患者中有2例有良性插管后狭窄和软化。总共植入了33个支架,或同时植入,或依次植入。对原型支架和其他市售硅酮支架均进行了扫描电子显微镜检查以作比较。
该治疗显著改善了患者的临床状况。新型假体的机械性能极佳。与支架相关的重要副作用有早期黏液潴留(7例)、内部硅酮层折叠(2例)和支架移位(2例)。截至1997年2月,10例患者死于与支架置入无关的原因。7例恶性气道疾病患者在初始治疗后存活2周至7个月。对取出的和未使用的原型支架进行扫描电子显微镜检查表明,管腔内极其粗糙的微观结构可能有助于分泌物的牢固黏附,而表面的技术平滑处理可避免此类并发症。
新型自膨胀硅酮气道支架可能是常用支架类型中很有前景的补充。对瘘、肿瘤表面出血和狭窄(恶性和良性)的短期和中期管理效果令人满意。支架的扫描电子显微镜检查提供了微观结构和材料独特特征的信息,这些信息可能对临床研究和技术创新有用。